1. Home
  2. USLM vs ZLAB Comparison

USLM vs ZLAB Comparison

Compare USLM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USLM
  • ZLAB
  • Stock Information
  • Founded
  • USLM 1948
  • ZLAB 2013
  • Country
  • USLM United States
  • ZLAB China
  • Employees
  • USLM N/A
  • ZLAB N/A
  • Industry
  • USLM Other Metals and Minerals
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • USLM Industrials
  • ZLAB Health Care
  • Exchange
  • USLM Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • USLM 3.0B
  • ZLAB 1.8B
  • IPO Year
  • USLM N/A
  • ZLAB 2017
  • Fundamental
  • Price
  • USLM $107.35
  • ZLAB $31.38
  • Analyst Decision
  • USLM
  • ZLAB Strong Buy
  • Analyst Count
  • USLM 0
  • ZLAB 4
  • Target Price
  • USLM N/A
  • ZLAB $52.50
  • AVG Volume (30 Days)
  • USLM 51.4K
  • ZLAB 976.3K
  • Earning Date
  • USLM 11-08-2024
  • ZLAB 11-12-2024
  • Dividend Yield
  • USLM 0.19%
  • ZLAB N/A
  • EPS Growth
  • USLM 35.43
  • ZLAB N/A
  • EPS
  • USLM 3.01
  • ZLAB N/A
  • Revenue
  • USLM $288,802,000.00
  • ZLAB $322,711,000.00
  • Revenue This Year
  • USLM N/A
  • ZLAB $48.34
  • Revenue Next Year
  • USLM N/A
  • ZLAB $47.12
  • P/E Ratio
  • USLM $35.32
  • ZLAB N/A
  • Revenue Growth
  • USLM 8.77
  • ZLAB 28.16
  • 52 Week Low
  • USLM $37.11
  • ZLAB $13.48
  • 52 Week High
  • USLM $107.39
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • USLM 76.73
  • ZLAB 70.41
  • Support Level
  • USLM $100.73
  • ZLAB $31.52
  • Resistance Level
  • USLM $104.96
  • ZLAB $36.60
  • Average True Range (ATR)
  • USLM 2.47
  • ZLAB 1.36
  • MACD
  • USLM 0.02
  • ZLAB 0.34
  • Stochastic Oscillator
  • USLM 92.96
  • ZLAB 58.60

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime, and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: